Interleukin-4 and -13 Inhibit Tumor Necrosis Factor-α mRNA Translational Activation in Lipopolysaccharide-induced Mouse Macrophages

Tatjana Mijatovic, Véronique Kruys, Daniel Caput, Patrick Defrance, Georges Huez

Journal of Biological Chemistry · 1997 · 112 citations · 33 references

DOIFull text

Open access

Concepts

Abstract

The production of tumor necrosis factor-α (TNF-α) by lipopolysaccharide (LPS)-stimulated macrophages can be markedly inhibited by the two closely related cytokines, interleukin (IL)-4 and IL-13. To investigate the molecular mechanism of this inhibition, we analyzed the effect of the two cytokines on TNF-α production and TNF-α mRNA accumulation in the mouse macrophage cell lines RAW 264.7 and J774 stimulated by LPS. Whereas LPS-induced TNF-α production is strongly suppressed by both cytokines, TNF-α mRNA accumulation is not significantly affected, indicating that IL-4 and IL-13 induce a translational repression of TNF-α mRNA. Transfection of reporter gene constructs containing different regions of the TNF-α gene revealed that the inhibitory action of IL-4 and IL-13 is mediated by the UA-rich sequence present in the TNF-α mRNA 3′-untranslated region. The production of tumor necrosis factor-α (TNF-α) by lipopolysaccharide (LPS)-stimulated macrophages can be markedly inhibited by the two closely related cytokines, interleukin (IL)-4 and IL-13. To investigate the molecular mechanism of this inhibition, we analyzed the effect of the two cytokines on TNF-α production and TNF-α mRNA accumulation in the mouse macrophage cell lines RAW 264.7 and J774 stimulated by LPS. Whereas LPS-induced TNF-α production is strongly suppressed by both cytokines, TNF-α mRNA accumulation is not significantly affected, indicating that IL-4 and IL-13 induce a translational repression of TNF-α mRNA. Transfection of reporter gene constructs containing different regions of the TNF-α gene revealed that the inhibitory action of IL-4 and IL-13 is mediated by the UA-rich sequence present in the TNF-α mRNA 3′-untranslated region. Tumor necrosis factor-α (TNF-α) 1The abbreviations used are: TNF-αtumor necrosis factor-αLPSlipopolysaccharideILinterleukinCMVcytomegalovirusCATchloramphenicol acetyltransferaseCSBPCSAID (cytokine-suppressive antiinflammatory drug) binding protein is a pleiotropic cytokine secreted by different cell types including macrophages, mastocytes, T and B lymphocytes, and natural killer cells in response to various stimuli (lipopolysaccharide (LPS), viruses, parasites, etc.) (1Beutler B. Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. 1992; Google Scholar). A wide variety of cell types express TNF-α receptors, and the pleiotropism of TNF-α results from the complexity of the signal transduction pathways that are activated by its receptors. TNF-α is characterized by cytostatic and cytolytic effects on tumor cells of different origins (2Sugarman B.J. Aggrawal B.B. Figari I.S. Hass P.E. Palladino Jr., M.A. Shepard H.M. Science. 1985; 230: 943-945Crossref PubMed Scopus (1371) Google Scholar), by antiviral properties (3Mire Sluis A. Trends Biotechol. 1993; 11: 74-77Abstract Full Text PDF PubMed Scopus (13) Google Scholar), and by its important role in the activation of the immune system upon host invasion (4Beutler B. Cerami A. Biochemistry. 1988; 27: 7575-7582Crossref PubMed Scopus (114) Google Scholar). TNF-α has also been identified as a major mediator of inflammatory processes, one of the most dramatic being Gram-negative endotoxic shock (1Beutler B. Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. 1992; Google Scholar). Indeed, upon exposure to LPS or other agents simulating host invasion, macrophages produce large amounts of TNF-α that are released in the circulatory system. High levels of circulating TNF-α trigger a state of shock and tissue injury that carries an extremely high mortality rate (1Beutler B. Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. 1992; Google Scholar). tumor necrosis factor-α lipopolysaccharide interleukin cytomegalovirus chloramphenicol acetyltransferase CSAID (cytokine-suppressive antiinflammatory drug) binding protein The expression of the TNF-α gene in mouse macrophages is regulated at the transcriptional (5Collart M. Bauerle P. Vassalli P. Mol. Cell. Biol. 1990; 10: 1498-1506Crossref PubMed Google Scholar, 6Read M.A. Whitly M.Z. Williams A.J. Collins T. J. Exp. Med. 1994; 179: 503-512Crossref PubMed Scopus (380) Google Scholar) and translational (1Beutler B. Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. 1992; Google Scholar) levels. In resting macrophages, TNF-α synthesis is low because TNF-α gene transcription is weak and TNF-α mRNA translation is severely repressed. The translational repression is mediated by the UA-rich sequence present in the TNF-α mRNA 3′-untranslated region (1Beutler B. Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. 1992; Google Scholar). Macrophage activation by LPS results in NF-κB-dependent activation of TNF-α gene transcription, derepression of TNF-α mRNA translation, and secretion of TNF-α protein. TNF-α production by macrophages can be down-regulated by various agents including cytokines like IL-4 and IL-13 (7Minty A. Chalon P. Derocq J.-M. Dumont X. Guillemont J.-C. Kaghad M. Labit C. Leplatois P. Liauzun P. Miloux B. Minty C. Casellas P. Loison G. Lupker J. Shire D. Ferrara P. Caput D. Nature. 1993; 362: 248-250Crossref PubMed Scopus (849) Google Scholar, 12Hart P.H. Jones C.A. Finlat-Jones J.J. Immunology. 1992; 76: 560-565PubMed Google Scholar). IL-4 and IL-13 are two closely related cytokines that are synthesized mainly by activated T lymphocytes (7Minty A. Chalon P. Derocq J.-M. Dumont X. Guillemont J.-C. Kaghad M. Labit C. Leplatois P. Liauzun P. Miloux B. Minty C. Casellas P. Loison G. Lupker J. Shire D. Ferrara P. Caput D. Nature. 1993; 362: 248-250Crossref PubMed Scopus (849) Google Scholar, 8O'Garra A. Spits H. Res. Immunol. 1993; 144: 567-651Crossref Scopus (7) Google Scholar). Both cytokines share many biological activities including the activation of B cell proliferation, IgE switching, and inhibition of inflammatory cytokine production (9de Vries J.E. Punnonen J. Cocks B.G. de Waal Malefyt R. Aversa G. Res. Immunol. 1993; 144: 597-601Crossref PubMed Scopus (64) Google Scholar, 10de Waal Malefyt R. Figdor C.G. Huijbens R. Mohan-Peterson S. Bennett B. Culpepper J. Dang W. Zurawski G. de Vries J.E. J. Immunol. 1993; 151: 6370-6381PubMed Google Scholar, 11de Waal Malefyt R. Figdor C.G. de Vries J.E. Res. Immunol. 1993; 144: 629-633Crossref PubMed Scopus (43) Google Scholar). TNF-α is one of the major inflammatory cytokines being repressed by IL-4 and IL-13. However, the molecular mechanism of this regulation has not been elucidated. In this study, we investigated the mechanism by which IL-4 and IL-13 down-regulate TNF-α production in LPS-stimulated mouse RAW 264.7 and J774 macrophages. We show that in these cell types, IL-4 and IL-13 inhibit LPS-induced TNF-α production mainly at the translational level. Furthermore, down-regulation of TNF-α mRNA translation by IL-4 and IL-13 is mediated by the UA-rich sequence present in its 3′-untranslated region. LPS from Escherichia coli (strain 0.127:B8) was obtained from Sigma. [α-32P]UTP (800 Ci/mmol) and [14C]chloramphenicol (56 mCi/mmol) were purchased from Amersham Life Science, Inc. Murine recombinant IL-4 and TNF-α were purchased from Genzyme. Purified murine IL-13 was obtained from Sanofi Elf Biorecherches, Labège, France. Both reporter constructs used in this study have been described elsewhere: CMV3′TNF in Ref. 13Han J. Huez G. Beutler B. J. Immunol. 1991; 146: 1843-1848PubMed Google Scholar and CMV3′TNFUA− in Ref. 14Marchant A. Gueydan C. Houzet L. Amraoui Z. Sels A. Huez G. Goldman M. Kruys V. J. Inflamm. 1996; 46: 114-123PubMed Google Scholar, referred to as construct 3. The murine macrophage cell lines RAW 264.7 and J774 were obtained from the American Type Culture Collection. The cells were maintained in Dulbecco's modified Eagle's medium containing 5% fetal bovine serum (FBS Myoclone Super Plus, Life Technologies, Inc.) and 1% penicillin/streptomycin. RAW 264.7 cells were cotransfected with each of the described constructs and pSV2Neo as described (15Peppel K. Vinci J.M. Baglioni C. J. Exp. Med. 1991; 173: 349-355Crossref PubMed Scopus (122) Google Scholar). Cells were first selected for 1 day with 0.3 mg/ml G418 sulfate, for 1 day with 0.6 mg/ml, and for 2 weeks with 1 mg/ml. The resistant clones were then pooled. The cells were stimulated simultaneously with LPS (10 ng/ml) and IL-4 (5 ng/ml) or IL-13 (5 ng/ml) unless otherwise specified. TNF-α levels were measured in cell supernatants by sandwich enzyme-linked immunosorbent assay using a polyclonal rabbit anti-mouse TNF-α antibody for coating and the same biotinylated polyclonal antibody for detection (generously provided by Dr. W. Buurman, University of Limburg Maastricht, The Netherlands). CAT assays were performed as described (17Gorman C.M. Moffat L.F. Howard B.H. Mol. Cell. Biol. 1982; 12: 1044-1051Crossref Scopus (5294) Google Scholar), and quantification of CAT activity was performed with a Molecular Dynamics PhosphorImager. Northern blot analysis was performed as described (16Kruys V. Thompson P. Beutler B. J. Exp. Med. 1993; 177: 1383-1390Crossref PubMed Scopus (45) Google Scholar) using 10 and 20 μg of total cytoplasmic RNA for TNF-α and CAT mRNA detection, respectively. Blots were hybridized with antisense riboprobes for TNF-α and CAT mRNAs (16Kruys V. Thompson P. Beutler B. J. Exp. Med. 1993; 177: 1383-1390Crossref PubMed Scopus (45) Google Scholar, 17Gorman C.M. Moffat L.F. Howard B.H. Mol. Cell. Biol. 1982; 12: 1044-1051Crossref Scopus (5294) Google Scholar). For quantification, the blots were rehybridized with a glyceraldehyde-3-phosphate dehydrogenase antisense riboprobe. RNA quantification was achieved by normalizing the radioactive signal corresponding to TNF-α mRNA to that of glyceraldehyde-3-phosphate dehydrogenase in the same RNA sample. RAW 264.7 mouse macrophages produce large amounts of TNF-α in response to LPS. Moreover, the transcriptional and post-transcriptional regulation of TNF-α biosynthesis by LPS is well characterized in this cell line. Therefore, RAW 264.7 cells provided an appropriate system to analyze the mechanism by which IL-4 and IL-13 suppress LPS-induced TNF-α production. We also analyzed the mechanism by which these cytokines down-regulate LPS-induced TNF-α production in J774 cells, which produce high levels of TNF-α upon LPS stimulation. A recent study has shown that depending on the time of exposure to IL-4 or IL-13 relative to LPS stimulation, IL-4 and IL-13 have either inhibitory or stimulatory effects on LPS-induced TNF-α production in human peripheral blood mononuclear cells (18D'Andrea A. Ma X. Aste-Amezaga M. Paganin C. Trinchieri G. J. Exp. Med. 1995; 181: 537-546Crossref PubMed Scopus (361) Google Scholar). When added to the cell culture 20 h or more before LPS stimulation, IL-4 and IL-13 prime LPS-induced TNF-α production, whereas when added simultaneously or a few hours before LPS stimulation, IL-4 and IL-13 exert a marked inhibitory effect on the production of this cytokine (18D'Andrea A. Ma X. Aste-Amezaga M. Paganin C. Trinchieri G. J. Exp. Med. 1995; 181: 537-546Crossref PubMed Scopus (361) Google Scholar). Therefore, before analyzing the mechanism by which these cytokines inhibit LPS-induced TNF-α production, we verified that IL-4 and IL-13, when added to the cell culture at the same time as LPS, could inhibit TNF-α production in RAW 264.7 and J774 cells. We performed experiments in which increasing concentrations of each cytokine were added to RAW 264.7 or J774 cell cultures simultaneously with LPS. TNF-α production was assayed by enzyme-linked immunosorbent assay using a polyclonal anti-mouse TNF-α antibody to measure the totality of TNF-α produced in response to the various treatments. As shown in Fig. 1, LPS-induced TNF-α production in RAW 264.7 cells was inhibited by both cytokines in a dose-dependent manner, reaching 72 and 63% inhibition at the highest doses of IL-4 and IL-13 tested, respectively (IL-4, 5 ng/ml; and IL-13, 5 ng/ml). Similarly, the highest doses of IL-4 and IL-13 inhibited TNF-α production in LPS-stimulated J774 cells by 65 and 67%, respectively. TNF-α production by LPS-stimulated mouse macrophages results from a combination of TNF-α gene transcriptional activation and TNF-α mRNA translational derepression. To determine at which level IL-4 and IL-13 inhibit LPS-induced TNF-α production, we analyzed LPS-induced TNF-α mRNA accumulation in the presence or absence of each cytokine. Since TNF-α mRNA accumulation peaks 2 h after LPS addition to the cell culture (19Han J. Beutler B. Huez G. Biochim. Biophys. Acta. 1991; 1090: 22-28Crossref PubMed Scopus (56) Google Scholar), we studied the effect of IL-4 and IL-13 on TNF-α mRNA accumulation at this time point after LPS induction. We observed that whereas both cytokines inhibited LPS-induced TNF-α production, TNF-α mRNA accumulation was not affected by IL-4 and IL-13 in RAW 264.7 cells (Fig. 2). In J774 cells, both IL-4 and IL-13 markedly suppressed LPS-induced TNF-α production, as previously observed. Northern blot analysis of TNF-α mRNA revealed that LPS-induced TNF-α mRNA accumulation was slightly reduced by IL-4 and IL-13 (Fig. 3). However, this 13% decrease cannot account by itself for the reduction of TNF-α production, which reached 60 and 80% in response to IL-4 and IL-13, respectively. Altogether, these results indicate that the suppressive effect of IL-4 and IL-13 on TNF-α biosynthesis is mostly if not completely exerted at the translational level in both cell lines.Figure 3Simultaneous analysis of TNF-α production (A) and TNF-α mRNA accumulation (B) in LPS-stimulated J774 cells in the presence or absence of IL-4 or IL-13. The induction of TNF-α production by LPS in the presence of either cytokine is expressed in percent, attributing 100% to the level of TNF-α produced by cells treated by LPS alone in comparison with the level of TNF-α produced by unstimulated cells. Results are the means ± S.E. of four separate experiments. TNF-α mRNA accumulation was quantified as described under “Materials and Methods,” attributing 100% to the TNF-α mRNA level obtained for cells treated with LPS alone. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was used as an internal control. Similar results were obtained in four separate experiments, with a maximal variation of 10% in the TNF-α mRNA level.View Large Image Figure ViewerDownload Hi-res image Download (PPT) As the 3′-untranslated region of the TNF-α mRNA plays a central role in the translational control of TNF-α gene expression, we analyzed the effect of IL-4 and IL-13 on the expression of a stably transfected CAT reporter gene containing this sequence (CMV3′TNF; Fig. 4) in RAW 264.7 cells. Indeed, former studies showed that in RAW 264.7 cells transfected with this construct, LPS stimulates the expression of the reporter gene by acting only at the translational level (13Han J. Huez G. Beutler B. J. Immunol. 1991; 146: 1843-1848PubMed Google Scholar). In unstimulated RAW 264.7 cells, the presence of the CMV promoter led to the constitutive accumulation of CMV3′TNF mRNA as evaluated by Northern blotting, but this mRNA was poorly translated in CAT protein (Fig.5 A). Upon stimulation with LPS, translational derepression resulted in CAT protein accumulation without significant variation of the CMV3′TNF mRNA. Exposure of the CMV3′TNF-transfected cells to LPS in combination with IL-4 or IL-13 markedly reduced the accumulation of CAT activity (Fig. 5 A) without affecting the level of CMV3′TNF mRNA. In contrast, IL-4 and IL-13 had no effect on the expression of the CMV3′TNFUA−construct, in which the UA-rich sequence is specifically deleted (see Figs. 4 and 5 B). As a control, we verified that the inhibition of LPS-induced TNF-α production by IL-4 and IL-13 in both transfected cell lines was equivalent to that observed in untransfected RAW 264.7 cells (data not shown). These results indicate that IL-4 and IL-13 suppress the expression of the CMV3′TNF reporter gene at the translation level and require the presence of the UA-rich sequence to exert their inhibitory action on TNF-α mRNA translation.Figure 5IL-4 and IL-13 inhibit LPS-induced translation of a CAT reporter construct containing the full-length TNF-α 3′-untranslated region. A, CAT activity and Northern blot analysis of CAT mRNA accumulation in RAW 264.7 cells stably transfected with the CMV3′TNF construct after stimulation with LPS alone or in combination with IL-4 or IL-13; B, CAT activity and Northern blot analysis of CAT mRNA accumulation in RAW 264.7 cells stably transfected with the CMV3′TNFUA− construct after treatment with LPS alone or in combination with IL-4 or IL-13. Cells were plated at a density of 10 × 106 cells in 10-cm dishes. When the cells were adherent, they were either untreated or treated with LPS (10 ng/ml) alone or in combination with IL-4 (5 ng/ml) or IL-13 (5 ng/ml). After 3 h of incubation, the cells were harvested. 106 cells were used to assay CAT activity, and 9 × 106 cells were used to extract cytoplasmic RNA for Northern blot analysis. CAT production is expressed in percent, attributing 100% to the level of CAT activity produced by the cells treated with LPS alone. The results show one representative out of three independent experiments. A maximal 10% variation was observed in the level of CAT mRNA accumulation and in the degree of inhibition of CAT protein production by IL-4 and IL-13. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; AcCM, acetylated forms of chloramphenicol; CM, chloramphenicol.View Large Image Figure ViewerDownload Hi-res image Download (PPT) It is well that in IL-4 and IL-13 which one of the major is the inhibition of cytokine production. Indeed, both IL-4 and IL-13 inhibit the production of cytokines including macrophage inflammatory and TNF-α by activated with LPS (7Minty A. Chalon P. Derocq J.-M. Dumont X. Guillemont J.-C. Kaghad M. Labit C. Leplatois P. Liauzun P. Miloux B. Minty C. Casellas P. Loison G. Lupker J. Shire D. Ferrara P. Caput D. Nature. 1993; 362: 248-250Crossref PubMed Scopus (849) Google Scholar, 10de Waal Malefyt R. Figdor C.G. Huijbens R. Mohan-Peterson S. Bennett B. Culpepper J. Dang W. Zurawski G. de Vries J.E. J. Immunol. 1993; 151: 6370-6381PubMed Google Scholar, 12Hart P.H. Jones C.A. Finlat-Jones J.J. Immunology. 1992; 76: 560-565PubMed Google Scholar, R. S. S. J. Immunol. 1993; 151: Google Scholar). The inhibitory effect of IL-4 and IL-13 on the production of TNF-α has been in human peripheral blood (7Minty A. Chalon P. Derocq J.-M. Dumont X. Guillemont J.-C. Kaghad M. Labit C. Leplatois P. Liauzun P. Miloux B. Minty C. Casellas P. Loison G. Lupker J. Shire D. Ferrara P. Caput D. Nature. 1993; 362: 248-250Crossref PubMed Scopus (849) Google Scholar, 10de Waal Malefyt R. Figdor C.G. Huijbens R. Mohan-Peterson S. Bennett B. Culpepper J. Dang W. Zurawski G. de Vries J.E. J. Immunol. 1993; 151: 6370-6381PubMed Google Scholar, 11de Waal Malefyt R. Figdor C.G. de Vries J.E. Res. Immunol. 1993; 144: 629-633Crossref PubMed Scopus (43) Google Scholar, 12Hart P.H. Jones C.A. Finlat-Jones J.J. Immunology. 1992; 76: 560-565PubMed Google Scholar, R. K. J. Immunol. Google S. A. PubMed Scopus Google Scholar), human macrophages S. H. G. A. K. T. J. 1992; Google Scholar), murine macrophages Waal Malefyt R. Figdor C.G. de Vries J.E. Res. Immunol. 1993; 144: 629-633Crossref PubMed Scopus (43) Google Scholar, R. S. S. J. Immunol. 1993; 151: Google Scholar) and murine macrophages S. J. Immunol. 1992; Google Scholar). The mechanism by which IL-4 and IL-13 inhibit LPS-induced TNF-α production in is For studies show that IL-4 and IL-13 decrease LPS-induced TNF-α mRNA accumulation in human peripheral blood mononuclear cells (7Minty A. Chalon P. Derocq J.-M. Dumont X. Guillemont J.-C. Kaghad M. Labit C. Leplatois P. Liauzun P. Miloux B. Minty C. Casellas P. Loison G. Lupker J. Shire D. Ferrara P. Caput D. Nature. 1993; 362: 248-250Crossref PubMed Scopus (849) Google Scholar, R. K. J. Immunol. Google Scholar, S. A. PubMed Scopus Google Scholar). However, one that in mouse macrophages, IL-4 not TNF-α mRNA accumulation in response to LPS S. J. Immunol. 1992; Google Scholar). The expression of the TNF-α gene in macrophages is regulated both at the transcriptional and post-transcriptional levels (1Beutler B. Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. 1992; Google Scholar). In unstimulated mouse macrophages, TNF-α production is severely repressed both at the transcriptional and translational levels. Indeed, under these TNF-α gene transcription is and TNF-α mRNA translation is translational repression is mediated by the UA-rich sequence in the 3′-untranslated region of TNF-α mRNA. Macrophage activation by LPS to a in TNF-α gene transcription and a in TNF-α mRNA translation, to an in TNF-α biosynthesis (1Beutler B. Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. 1992; Google Scholar). regulation of TNF-α mRNA also plays an important role under other Indeed, LPS which is characterized by an TNF-α production in response to a LPS is mainly to a translation of TNF-α mRNA A. Gueydan C. Houzet L. Amraoui Z. Sels A. Huez G. Goldman M. Kruys V. J. Inflamm. 1996; 46: 114-123PubMed Google Scholar). Furthermore, production of TNF-α in response to by and results to a from TNF-α mRNA translational activation V. Kruys V. T. Huez G. J. Inflamm. 1996; 46: Scholar). In study, we at the mechanism by which IL-4 and IL-13 inhibit LPS-induced TNF-α production in the mouse macrophage cell RAW in which the regulation of TNF-α biosynthesis is well Furthermore, we also investigated this mechanism in mouse macrophage cell which also high levels of TNF-α in response to LPS. We first verified that IL-4 and IL-13 down-regulate TNF-α production in both cell types when added to the cell culture at the same time as LPS. We then that under these both cytokines inhibit LPS-induced TNF-α production without significantly affecting TNF-α mRNA Therefore, we that IL-4 and IL-13 down-regulate TNF-α gene expression at the translational level. analyzing the effect of IL-4 and IL-13 on the expression of CAT reporter constructs with or without the TNF-α mRNA UA-rich sequence in RAW 264.7 cells, we show that both IL-4 and IL-13 exert their inhibitory action on mRNA translation the of this UA-rich we have identified in RAW 264.7 cells a protein that the TNF-α mRNA UA-rich sequence upon stimulation with LPS C. Houzet L. A. Sels A. Huez G. Kruys V. Mol. Med. 1996; PubMed Google Scholar). The LPS-induced binding of this to the UA-rich sequence is by the protein A. The that IL-4 and IL-13 TNF-α mRNA translation that IL-4 and IL-13 with the binding of this protein to the UA-rich sequence upon LPS stimulation. The mechanism by which this is However, is well that stimulation of macrophages by LPS of various of the protein including protein protein and its human and in an in their activity K. J. Biol. 1992; Full Text PDF PubMed Google Scholar, Z. X. J. Exp. Med. 1993; 177: PubMed Scopus Google Scholar, J. J. Biol. 1993; Full Text PDF PubMed Google Scholar, Thompson P. Beutler B. Mol. Med. 1994; PubMed Google Scholar, J. L. Science. 1994; PubMed Scopus Google Scholar, S. D. D. J.E. Nature. 1994; PubMed Scopus Google Scholar). of and activity specifically LPS-induced TNF-α mRNA translation by TNF-α mRNA upon LPS stimulation W. A. J. D. J. Inflamm. 1995; Google Scholar). These indicate that and are the that TNF-α mRNA translational activation most by the binding of the protein to the UA-rich IL-4 and IL-13 down-regulate LPS-induced TNF-α mRNA Both cytokines share a IL-4 which is for A. W. 1996; Google Scholar). Upon IL-4 or IL-13 stimulation, IL-4 on and including which also on forms a containing the and and the as or L. H. J. Biol. 1995; Full Text Full Text PDF PubMed Scopus Google Scholar, W. Mol. Cell. Biol. 1995; PubMed Google Scholar). no from and have been observed upon stimulation, and the of their by We can that upon IL-4 or IL-13 stimulation, the activity of down-regulate the activity of or and by their the LPS-induced binding of the protein to the UA-rich sequence and TNF-α mRNA translation be We Dr. W. for the polyclonal rabbit anti-mouse TNF-α antibody used in the mouse TNF-α enzyme-linked immunosorbent We B. and J. for the We Dr. for of the

References

33